Olufunmilayo Olopade is the co-founder and chief scientific advisor at CancerIQ, a board certified internist and medical oncologist, Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics, associate dean of Global Health, and director for the Center for Clinical Cancer Genetics at The University of Chicago. An expert in individualized treatment for the most aggressive forms of breast cancer, Dr. Olopade is a leader in women’s health. She is a strong proponent for population risk stratification to effectively manage risk of chronic non-communicable diseases across the lifespan and improve health and well being in diverse populations and social backgrounds. Dr. Olopade holds an MBA from Wharton.